A University of New England professor has been awarded a $1.7 million federal grant to research medications that would potentially reduce nerve pain in some HIV patients.

Dr. Ling Cao, a professor of biomedical sciences at the University of New England, won the National Institutes of Health grant for a five-year study to “further understand HIV-associated neuropathy. This nerve-damaging condition often manifests as hard-to-treat pain and affects about half of the people living with HIV,” the university said in a statement.

Cao said the research “enables her lab to make real contributions to eventual drug development.” There is no current FDA-approved drug to treat HIV-associated neuropathy.

“With the advancement of antiretroviral treatment, people with HIV live longer and are more likely to experience HIV-associated chronic complications, such as HIV sensory neuropathy,” Cao said, “Clinically, it is hard to distinguish HIV sensory neuropathy from other similar peripheral neuropathies.”


Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.